Gut bacteria molecule may ease colitis by slowing cellular energy production

Researchers discovered that enterobactin, a molecule produced by gut bacteria, may reduce intestinal inflammation in colitis by slowing cellular energy production—a novel mechanism that could lead to new therapeutic approaches.

This does not prove the treatment is safe or effective in humans; it appears to be early-stage research findings that require further development and clinical testing.